Pharmaceutical Industries Ltd.
Menu
Health Products
WCAG 2.0
Print

Taro-Lenalidomide, Capsules
« Back to list view

Product Information

  • DIN:
    02507862
  • Active Ingredients :
    lenalidomide
  • Innovator Name:
    REVLIMID®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    2.5 mg
  • Route of Administration:
    Oral
  • Package size:
    21 Blister
  • UPC Code:
    063691100879
  • Description :
    Blue green opaque cap and white opaque body, with "RL, 78" black imprint.
  • Non-medicinal ingredients :
    black iron oxide, croscarmellose sodium, FD&C Blue 2 (for 2.5 mg, 10 mg, 15 mg, 20 mg only), gelatin, iron oxide yellow (for 2.5 mg, 10 mg, 20 mg only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, potassium hydroxide, propylene glycol, shellac and titanium dioxide
Taro-Lenalidomide, Capsules

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02507870
  • Active Ingredients :
    lenalidomide
  • Innovator Name:
    REVLIMID®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    5 mg
  • Route of Administration:
    Oral
  • Package size:
    28 Blister
  • UPC Code:
    063691100886
  • Description :
    White opaque cap and white opaque body, with "RL, 79" black imprint.
  • Non-medicinal ingredients :
    black iron oxide, croscarmellose sodium, FD&C Blue 2 (for 2.5 mg, 10 mg, 15 mg, 20 mg only), gelatin, iron oxide yellow (for 2.5 mg, 10 mg, 20 mg only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, potassium hydroxide, propylene glycol, shellac and titanium dioxide
Taro-Lenalidomide, Capsules

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02507889
  • Active Ingredients :
    lenalidomide
  • Innovator Name:
    REVLIMID®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    10 mg
  • Route of Administration:
    Oral
  • Package size:
    28 Blister
  • UPC Code:
    063691100893
  • Description :
    Blue green opaque cap and pale yellow opaque body, with "RL, 80" black imprint.
  • Non-medicinal ingredients :
    black iron oxide, croscarmellose sodium, FD&C Blue 2 (for 2.5 mg, 10 mg, 15 mg, 20 mg only), gelatin, iron oxide yellow (for 2.5 mg, 10 mg, 20 mg only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, potassium hydroxide, propylene glycol, shellac and titanium dioxide
Taro-Lenalidomide, Capsules

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02507897
  • Active Ingredients :
    lenalidomide
  • Innovator Name:
    REVLIMID®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    15 mg
  • Route of Administration:
    Oral
  • Package size:
    21 Blister
  • UPC Code:
    063691100909
  • Description :
    Powder blue opaque cap and white opaque body, with "RL, 81" black imprint.
  • Non-medicinal ingredients :
    black iron oxide, croscarmellose sodium, FD&C Blue 2 (for 2.5 mg, 10 mg, 15 mg, 20 mg only), gelatin, iron oxide yellow (for 2.5 mg, 10 mg, 20 mg only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, potassium hydroxide, propylene glycol, shellac and titanium dioxide
Taro-Lenalidomide, Capsules

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02507900
  • Active Ingredients :
    lenalidomide
  • Innovator Name:
    REVLIMID®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    20 mg
  • Route of Administration:
    Oral
  • Package size:
    21 Blister
  • UPC Code:
    063691100916
  • Description :
    Blue green opaque cap and powder blue opaque body, with "RL, 82" black imprint.
  • Non-medicinal ingredients :
    black iron oxide, croscarmellose sodium, FD&C Blue 2 (for 2.5 mg, 10 mg, 15 mg, 20 mg only), gelatin, iron oxide yellow (for 2.5 mg, 10 mg, 20 mg only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, potassium hydroxide, propylene glycol, shellac and titanium dioxide
Taro-Lenalidomide, Capsules

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Product Information

  • DIN:
    02507919
  • Active Ingredients :
    lenalidomide
  • Innovator Name:
    REVLIMID®
  • Category:
    Antineoplastic Agent
  • Dosage form:
    Capsule
  • Strength:
    25 mg
  • Route of Administration:
    Oral
  • Package size:
    21 Blister
  • UPC Code:
    063691100923
  • Description :
    White opaque cap and white opaque body, with "RL, 83" black imprint.
  • Non-medicinal ingredients :
    black iron oxide, croscarmellose sodium, FD&C Blue 2 (for 2.5 mg, 10 mg, 15 mg, 20 mg only), gelatin, iron oxide yellow (for 2.5 mg, 10 mg, 20 mg only), lactose monohydrate, magnesium stearate, microcrystalline cellulose, potassium hydroxide, propylene glycol, shellac and titanium dioxide
Taro-Lenalidomide, Capsules

All brand names and trademarks referenced remain the property of their respective owners.

To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.

For Provincial Formulary Status click here

Health Products
WCAG 2.0

Copyright © Taro Pharmaceutical Industries Ltd.

Privacy Statement | Terms of Use | Safe Harbor Statement